Under the agreement, clinical laboratory customers around the world continue to have access to the largest portfolio of coagulation instruments and tests. The companies will also continue joint product development activities ensuring customers have continued access to new coagulation technology.
“Our shared value to deliver quality products and services that address our customers’ needs is a key contributor to the success of our 14-year partnership,” said Donal Quinn, CEO, Siemens Healthcare Diagnostics. “Together, we expect to offer customers the broad, high-quality portfolio of coagulation products they have come to expect from us today and also deliver next-generation technology in the future.”
“We are pleased to continue our long-standing relationship with Siemens Healthcare,” said Hisashi Ietsugu, President and CEO, Sysmex Corporation. “Our partnership combines the strengths of two leading diagnostic companies whose joint expertise offers best-in-class solutions for the laboratory, and we look forward to expanding the clinical utility of these solutions cooperatively."
The wide variety of coagulation instruments and tests covered in this agreement are used by clinical laboratories to test for blood disorders in patients or to monitor patients on blood-thinning medication. The agreement also includes access to automated platelet function testing.
Source: Siemens Healthcare